Global Retinoblastoma Outcome Study | Análise baseada em grupos e prospectiva de 4.064 pacientes de 149 países.

The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries – The Lancet Global Health

Comentário convidado: Retinoblastoma as a lens for correctable disparities worldwide – The Lancet Global Health

Comunicado de imprensa: Children in low-income countries 16 times more likely to die from most common eye cancer – London School of Hygiene & Tropical Medicine